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Directed Studies 
• HRP Unique Processes, Criteria, and Guidelines 
(UCPG) – “Research tasks that are initiated 
without being competed … awarded directly to 
Principal Investigators (PIs) with the requisite 
skills to accomplish the work.”
• Criteria: a) insufficient time for solicitation; b) 
highly constrained research.
• Choice by Bone Discipline Lead
• Building upon research data -- to meet 
aggressive schedule for Path to Risk Reduction 
[PRR] 
Notably, 
• Perceived refinements are not from SD - Space 
and  Clinical Operations and not from SK 
investigators, per se.
• Translation of research data to SD previously 
attempted by team of SK investigators 2007 –
2009
• As Bone Risk Custodian convened a Bone 
Summit in 2010 – panel of osteoporosis experts 
– to address clinical risk management
Journal of Bone & Mineral 
June 28(6):1243-1255, 2013
“Bone Summit I – 2010”
HRP slide courtesy C. Kundrot
Adapted Sibonga 2012
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Use of  the Research Clinical Advisory Panels [RCAP] to 
prioritize NASA’s Human Research for Bone Risks
Evidence Base –
Flight and Ground
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• Clinical
• Operational 
experience
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Research Tasks
Bone Summit II - Bottom Line
“ Overall, NASA’s strategy of assessing relative fracture risk in 
astronauts by T-score BMD-based guidelines alone needs to be 
refined. Accurately determining the absolute fracture risk in 
astronauts is an ambitious goal that may never be fully realized. A 
concerted effort however should be made to expand NASA’s 
technical and scientific capabilities toward objectively assessing 
the factors contributing to the risk since long-duration space flight 
is expected to: 
i) have profound and possibly irreversible bone changes that 
would not be adequately addressed by DXA BMD,
ii) affect other physiological systems (e.g., muscle) that determine 
fracture likelihood and
iii) expose astronauts to novel situations that involve a greater 
probability of overloading bones.”
What do we define here,   to mitigate fractures.
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Fracture probability dependent upon 
data being assessed.
1. What & when are surveillance measurements required 
for collection?
2. LTH: Bone Summit identified  the lack of recovery as a 
critical trigger – and not just BMD.
3. OPS: probability of overloading of bones (task-related). 
4. Early LTH – immediately after return (e.g., 1-3 years) 
related to activity level and limited test
5. NASA’s Bone Fracture Module - not sensitive to 
changes in BMD due to ARED exercise or 
Bisphosphonates – due to large variability.  
6. Proposed – using bone strength calculated by Finite 
element modeling to reduce the uncertainty.
Study on Risk Surveillance: Hip QCT
• Test feasibility of QCT protocol for 
surveillance of identified clinical 
trigger (later).
• Accumulate surveillance data for 
development of clinical practice 
/intervention guidelines (QCT and 
FEM)
• Research: Demonstrate how QCT 
can delineate biochemical from 
mechanical countermeasures.  
“Proof of Concept” Pilot Study
Figures courtesy of T. Lang (UCSF) and D. Carter (Stanford U)
DXA vs. QCT Spine: 
Discordant Recovery Patterns in Astronauts After 
Spaceflight
QCT Extension Study (n=8) Postflight Trabecular BMD in hip.  Carpenter, D et al. Acta Astronautica, 2010.
tBMD – trabecular volumetric bone mineral density g/cm3
aBMD – areal bone mineral density g/cm2
*
DXA vs. QCT Hip:
Why the clinical concern? 
QCT Extension Study (n=8) Postflight Trabecular BMD in hip.  Carpenter, D et al. Acta Astronautica, 2010.
tBMD – trabecular volumetric bone mineral density g/cm3
aBMD – areal bone mineral density g/cm2
Lower trabecular BMD of hip is an independent 
predictor of hip fracture in elderly men.
Surveillance of mitigation and recovery is 
warranted – hypothesis should not be required.
QCT measures -- useful information regarding 
etiology of hip fracture, evaluation of hip fracture risk 
and possible targets for intervention.
Flight Study– Reductions in Hip Strength with 
spaceflight. 
Loading 
Condition
Mean (SD)
Pre-flight
Mean (SD)
Post-flight p
Stance 13,200 N
(2300 N)
11,200 N
(2400 N)
<0.001
Fall 2,580 N
(560 N)
2,280 N
(590 N)
0.003
N=11 crewmembers
Keyak et al Bone. 2009 Mar;44(3):449-53
BMD accounts for 50-70% bone 
strength
QCT estimates fracture loads
better than DXA 
R2=.66
QCT
R2 =.57
DXA
R2 =.84
FEMDD Cody:  Femoral strength is better predicted  by finite 
element models than QCT and DXA.  J Biomechanics  
32:1013 1999.
QCT + FEM has superior capabilities for 
estimating fracture loads
Finite 
Element 
Strength
BMD
Geometry Material Properties
Loading
Individualized
Fracture Risk
FEM of QCT data integrates multiple factors 
associated with fracture for single composite number 
to estimate bone strength. 
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NASA’s Probabilistic Risk Assessments for 
Model for Fracture – using QCT+ FEM
Bone Loss in 
Space
courses.washington
.edu/me598rc 
Biomechanics 
and Mission 
Operations
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Figure 2.  Summary of literature survey on fracture load as a function of femoral 
neck BMD 
Clinical and 
Engineering 
Characteristics of 
Bone Strength
Estimate of 
Fracture Probability
Probability of 
Fracture
Probability bone 
will fail to 
support load
Probability of 
event
Slide courtesy of J Myers; Adapted by Sibonga
Rationale late 1990’s: NASA develops 
standards for Crew Health Based on World 
Health Organization (WHO)
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Data slide courtesy of Keyak.  REPRESENTATIVE POPULATION DATA
Minimum Permissible
Outcome
Minimum FE strength 
for Bone Health
RESEARCH: Hypothetical FE Cutoffs (N or kN) for “Operating 
Bands of Bone Health”- i.e., are hips strong enough to account for 
declines due to spaceflight and to aging- to be used together with 
DXA BMD Standards.
Clinical Validation of Innovative Technologies: 
Bone Disruption in Microarchitecture
Predisposed to “codfish” fx
Male Astronauts?
Spaceflight Effect?
The Hip?
“plates” TbTh “rods” 
TbTh
TbN
TbSep
Microarchitectural Measures of Trabeculae and 
of Spatial Orientation
Adapted
Exploring Magnetic Resonance 
Technologies for Hip Bone Microarchitecture
• Virtual biopsy software (Acuitas: fineSA™)
• Easily translatable to any clinical or preclinical imaging system (No 
new hardware, No modifications)
• Innovative surface coils (and pulse sequences) show for MR-based 
assessments of trabecular structure in the proximal femur (Chang, 
NYUMC)
Source: www.acuitasmedical.com
To Sum, Directed Studies in Bone 
• Feasibility of using QCT for fracture risk 
surveillance – collects data that are BMD-
independent predictors of hip fracture
• Developing a “decision-making tool” using FE 
modeling of hip bone strength derived from 
astronauts and from population studies with 
fracture outcome.
• Testing new technologies for bone 
microarchitecture that do not require ionizing 
radiation.
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Consequence: Premature fragility fractures in 
astronauts due to previous exposure to spaceflight?
Cooper and Melton, 1992SLIDE COURTESY OF Dr. S. AMIN, Mayo Clinic
DXA measurement of areal BMD [BMDa] – a inferred 3d measure from a 
2d unit.
•Improved precision
• Low radiation
• Shorter scan times 
• BMD measures over multiple skeletal sites
• Numerous studies: distribution of BMD in populations with fracture 
outcome
• Widely-applied surrogate for fracture – but for is it a good index for bone 
strength?
Dual-energy X-ray Absorptiometry-DXA
Hip QCT for surveillance: BMD changes in 
separate bone types, in response to 
countermeasures
Index 
DXA 
 
%/Month 
Change + SD 
Index 
QCT 
%/Month 
Change + SD  
aBMD Lumbar 
Spine 
1.06+0.63* Integral vBMD 
Lumbar Spine 
 
0.9+0.5 
 
 
 
  Trabecular 
vBMD Lumbar 
Spine 
 
0.7+0.6 
aBMD Femoral 
Neck 
1.15+0.84* Integral vBMD 
Femoral Neck 
 
1.2+0.7 
  Trabecular 
vBMD 
Femoral 
 Neck 
 
2.7+1.9 
aBMD 
Trochanter 
1.56+0.99* Integral vBMD 
Trochanter 
 
1.5+0.9 
*p<0.01,  
n=16-18 
 Trabecular 
vBMD 
Trochanter 
2.2+0.9 
 
LeBlanc, J M Neuron Interact, 2000; 
Lang , J Bone Miner Res, 2004; (n=16 ISS)
Vico, The Lancet 2000
NOT detectable by DXA
Age: important risk factor for bone 
loss and fracture probability.
Kanis et al JBMR 9(8):1137, 1994
However, Paradigm Shift for assessing 
changes in Bone Strength as contributor to 
Fracture Risk.
• “Osteoporosis is a skeletal disorder characterized by 
compromised bone strength predisposing to an 
increased risk of fracture.  Bone strength reflects the 
integration of two main features: bone density and bone 
quality.”  JAMA 2001
• Why is this?
Bone fragility is influenced by factors that are not 
detected by DXA BMD.
Disconnects discovered
In population studies –
in response to 
countermeasures.
FRACTURE CASES
NON FRACTURES
How is DXA BMD used at JSC?
• Monitor skeletal health in all active and retired 
astronauts 
• Characterize skeletal effects of long-duration
spaceflight
• Evaluate efficacy of bone loss countermeasures
• Verify restored health status
However, diagnostic guidelines using areal BMD T-
scores provide relative risk, but cannot predict who will 
fracture. Not useful when used alone.
DXA BMD, not T-scores,  reveals changes that are unique 
& complex.  Drives requirement for research.
Rapid (1-1.5%/mo) and 
site-specific BMD loss  
(means local regulation
occurring).
Total BMD loss greater and persist compared to BMD changes
predicted from algorithms derived from earth-based  population
Loss is variable due 
to multiple risk 
factors. Recovery is 
variable. Recovery 
is prolonged. But 
ARED can reduce 
BMD decline in hip.-15
-5
5
15
0 500 1000 1500 2000
Mary Bouxsein, Ph.D. Bone Geometry and Skeletal Fragility, May 2005
However, DXA is limited as Research Tool: Does not account
for changes in bone size which impacts bone strength.
g/cm22
QCT quantifies volumetric BMD
DXA reports areal BMD (aBMD)
Densitometry & Reported Measurement 
g/cm2  averaged for cortical + trabecular bone
g/cm3 for separate  cortical & trabecular bones
Slide adapted from T. Lang., JBMR 2006.
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Surveillance by QCT– Changes in Femoral Neck structure
detected  12 months postflight
QCT in Population Study measures 
changes in bone size with aging.
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Suggests that outward displacement of femoral neck is response 
to cortex thinning with age 
Postmenopausal women
Premenopausal women
**
Riggs et al. JBMR19:1945, 2004.
Bone Turnover
Slide Courtesy of Dr. SM Smith; Adapted by Sibonga
Bone Turnover Markers indirectly suggest a net loss 
in bone mass from the entire skeleton.  
Exercise during Spaceflight does not mitigate 
urinary calcium excretion – as a biomarker for 
bone breakdown
Slide courtesy of Dr. A. LeBlanc
JBMR 27(9):1896-1906.
* Updated data since 2010 Bone Summit
Changes in areal BMD--useful information, 
but not a fracture predictor
Bone RCAP Recommendations (2010)
1. Use QCT for risk surveillance data . To detect clinical 
trigger recovery in hip trabecular BMD.  Conduct scans 
Pre- Post-, 1 year, 2 years (if recovery not established 
at 1 y)
2. QCT data required to formulate recommended clinical 
practice guidelines – which are driven by fracture probability.
3. Individualize risk assessments – due to data constraints.
4. Modify Bone crew health standards to be more relevant 
to LD astronaut experience.  Explore population studies with 
hip bone strength estimated by Finite Element analysis.  
5. Search/validate new technologies to assess unique 
changes due to spaceflight, e.g., bone microarchitecture of  
central skeletal sites.
Investigate a  new medical standard for BONE 
with Finite Element Modeling [FEM] :  
What is it and what can it tell NASA about hip 
fracture risk in the long-duration astronaut?
Images courtesy of Dr. J Keyak
FEM – a computational tool to estimate failure loads 
(“strength”) of complex structures - from models 
developed from QCT scans.
J. Keyak et al, 1998, 2001, 2005
Describing changes in hip bone strength with Finite 
Element Modeling/Analysis: 
Emerging data from population studies. 
• Male-female differences in prediction of hip fracture during finite 
element analysis. Keyak JH, Sigurdsson S, Karlsdottir G, Oskarsdottir D, 
Sigmarsdottir A, Zhao S, Kornak J, Harris TB, Sigurdsson G, Jonsson BY, 
Siggeirsdottir K, Eiriksdottir G, Gudnason V, Lang TR. Bone. 
2011;48(6):1239-1245.
• Association of hip strength estimates by finite –element analysis with 
fractures in women and men. Amin S,, Kopperdahl DL, Melton LJ 3rd, 
Achenbach SJ, Therneau TM, Riggs BL, Keaveny TM, Khosla S. J Bone 
Miner Res. 2011;26(7):1593-1600.
• Age-dependence of femoral strength in white women and men. 
Keaveny TM, Kopperdahl DL, Melton III LJ, Hoffmann PF, Amin S, Riggs 
BL, Khosla S. J Bone Miner Res. 2010;25(5):994-1001.
• Osteoporotic Fractures in Med Study Group. Finite element analysis of 
the proximal femur and hip fracture risk in older men. Orwoll ES, 
Marshall LM, Nielson CM, Cummings SR, Lapidus J, Cauley JA, Ensrud K, 
Lane N, Hoffmann PR, Kopperdahl DL, Keaveny TM J Bone Miner Res. 
2009;24(3):475–483.
FE Strength Cutoffs* Task Group
E. Orwoll MD, S Khosla MD, S Amin MD, T Lang PhD, J Keyak PhD, T Keaveny PhD, D Cody PhD, 
JD Sibonga, Ph.D.
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Data slide courtesy of Keyak.  REPRESENTATIVE POPULATION DATA
*Red, Yellow
and Green 
Operating Bands
Why Bone Microarchitecture?
• “…low bone mass and microarchitectural deterioration with a 
consequent increase in bone fragility with susceptibility to fracture 
….”  Am. J. Med.1991 Defined Contribution
• Disrupted microarchitecture is associated with vertebral 
compression fractures. Validated Fracture Predictor
• Bone Summit RCAP 2010:  concern for rapid bone loss in 
astronauts and aggressive osteoclast activity disrupting bone 
microarchitecture --- which is not detectable by QCT. Orwoll, 2013 
JBMR review
“plates” TbTh “rods” TbTh
TbN
TbSep
Indices of bone microarchitecture reflect changes in trabeculae size 
and spatial orientation – need to identify non-permissible outcome
Adapted by Sibonga
GAP MANAGEMENT FOR 
OSTEO & FRACTURE
Integrated Research Plan for Bone Portfolio
Osteo 4: We don’t know the contribution 
of each risk factor on bone loss and 
recovery of bone strength and which 
factors are the best targets for 
countermeasure application.  
KNOWLEDGE GAP - DATA
Osteo 1: A new acceptable bone health 
standard using an improved surrogate for 
bone strength needs to be defined for the 
flight environment.  
POLICY ON STANDARDS
Osteo 2: What is the incidence & 
prevalence of early onset osteoporosis of 
fragility fractures due to exposure to 
spaceflight? 
KNOWLEDGE GAP - EVIDENCE
Osteo 5: We need an in-flight capability 
to monitor bone turnover and bone 
mass changes during spaceflight.  
MITIGATION GAP - DETECT
Osteo 7:  We need to identify options 
for mitigating early onset osteoporosis 
before, during and after spaceflight.  
MITIGATION GAP – PREVENTION & 
TREATMENT
Osteo 3: We need a validated, clinically-
relevant method for assessing the effect 
of spaceflight on osteoporosis or fracture 
risk in LD astronauts. 
KNOWLEDGE GAP – ENABLING 
TECHNOLOGY
Gaps to define the changes to bone and the 
contribution to fracture risk.
Osteo 6:  How do skeletal changes 
due to spaceflight modify the terrestrial 
risk of osteoporotic fractures?  
MITIGATION GAP – SURVEILLANCE*MRIDs
ISS
*MRIDs -refer to data from medically-required tests Medical Requirements Integrated Document
Gaps to understand the Risk for 
Bone Fracture=Applied Loads/Bone Failure Loads
B30: What are the loads applied to 
bone in-flight and during EVA activities 
and do they increase fracture risk in 
light of expected bone loss?
B31:  Need additional information 
regarding hard and soft tissue healing 
in-flight. If impaired healing exists, 
what countermeasures can enhance 
healing?
Fracture 2. We need to characterize 
the loads applied to bone for 
standard in-mission activities.
Fracture 1. We don’t understand 
how the space flight environment 
affects bone fracture healing in-
flight.
Fracture 3. We need a validated 
method to estimate the Risk of 
Fracture by evaluating the ratio of 
applied loads to bone fracture loads 
for expected mechanically-loaded 
activities during a mission.
B2: What new technologies are 
available for in-flight fracture 
diagnosis?
Exploration Medical Capabilities
Summary
¾ DXA BMD, as a sole index, is an insufficient surrogate for fracture
¾ CPGs using BMD (both WHO and FRAX) are not specific for 
complicated subjects such as young, healthy persons following 
prolonged exposure to skeletal unloading (i.e. an attribute of 
spaceflight)
¾ Research data suggest that spaceflight induces changes to 
astronaut bones that could be profound, possibly irreversible and 
unlike age-related bone loss on Earth.
¾ There is a need to objectively assess factors across human 
physiology that are also influenced by spaceflight  (e.g., muscle) that 
contribute to fracture risk.
Summary 2
¾ Some of these objective assessments may require innovative 
technologies, analyses and modeling.
¾ Astronauts are also exposed to novel situations that may overload 
their bones highlighting a need integrate biomechanics  of physical 
activities into risk assessments.
¾ As we accumulate data, which reflects the biomechanical 
competence of bone under specific mechanically-loaded scenarios 
(even activities of daily living), BONE expects Bone Fracture Module 
to be more sensitive and/or have less uncertainty in its 
assessmentsof fracture probability.
¾ Fracture probability drives the requirement for countermeasures.  
Level of evidence will unlikely be obtained; hence, the Bone RCAP 
(like a Data Safety Monitoring Board) will provide the 
recommendations.
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Backup Slides
Monitoring microarchitectural changes: Establish
when perforation may occur. Mechanism of disruption 
informs countermeasure (anti-resorptive or anabolic)
Electron Microscopic Images to demonstrate mechanism of disruption ONLY
3235
AGE-REGRESSIONS: Bone loss occurs at 
earlier age than expected.
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History of Bone Imaging in Space
ApolloMercury
Gemini
Skylab
Space Shuttle
ISS
1961-63 1965-66 1968-72
• X-ray 
densitometry
• SPA  heel 
and wrist
• SPA  heel 
and wrist
1973-74 2000-present
Soyuz/Salyut
1974-85
• SPA  
• DPA
Mir
• DXA whole body
• CT of  lumbar spine 
BMD
1974-85
• DXA
• QCT
• HR3DpQCT
(ESA)
Slide adapted from by Amin, Mayo Clinic
Individual Results
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Adapted from: Pathogenesis of Osteoporosis-Related Fractures (NOF) Cooper C, Melton LJ
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ASTRONAUTS EXPOSED TO UNIQUE SET OF POSSIBLE RISK 
FACTORS DURING SPACEFLIGHT
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Risk Summary
L x C Driver: OPS Likelihood all except Planetary: < 0.1% likelihood of bone 
fracture in mission due to existing countermeasures (evaluated by BMD metric) 
effectiveness. Planetary: Increases due to mission duration and surface operations.  
Consequence LEO, Sortie, Lunar:  Greater performance impacts due to LOM as 
bone fracture may be considered a significant injury with possible return to Earth for 
treatment. Consequence Deep Space Journey and Planetary :  Based solely on 
health impacts - Injury may be disabling due to the inability to return to Earth for 
treatment. LTH Likelihood LEO, Lunar, Journey: Likelihood of fracture due to 
spaceflight > 0.1% and < 1%.  Most crew could return to baseline  BMD within 3 
years.   Sortie:  Likelihood <0.1% due to limited mission duration.  Planetary:  > 1% 
due to mission duration.  LTH Consequence:  Bone fracture prevention may require 
extended medical interventions by known methods
Risk Title: Risk of Bone Fracture due to Spaceflight-induced Changes to Bone*
Risk Statement: Given that space flight may induce adverse changes in bone ultimate strength with respect to mechanical loads during and post-
mission, there  is a possibility a fracture may occur for activities otherwise unlikely to induce fracture prior to initiating space flight. 
Primary Hazard: P-gravity Secondary Hazard: Radiation, Closed Environment (spacecraft 
design), 
Countermeasure: Prevention:
selection standard, exercise, task design, 
diet, pharmaceuticals. Treatment:  In-
flight treatment/medical kit 
pharmaceuticals, post-mission rehab.
Contributing Factors: Physiological deconditioning (e.g., visual and gait impairments) and clinical factors (e.g., nutrition 
and neuro-muscular declines), radiation, insufficient accommodations for occupant safety and operational tasks, and detailed mission 
design (mission design will be closely monitored; when such details are made available, the team will ensure sub-optimal design 
choices are not implemented to the detriment of human health and performance). 
State of Knowledge: Fracture probability is dependent upon loading and bone strength.  BMD is widely used as a surrogate for bone strength but its sole use 
recognized to be insufficient for risk assessment. Extensive pre/post flight Bone Mineral Density data.  ARED/T2 6 days/week exercise regimens have minimized declines in 
BMD, which are consistent with Permissible Outcome Limits (POL). It is important to point out that the standard POL was met before ARED/T2 were implemented on the 
ISS; however, this may reveal the possible inadequacy of the current standard metric, which is currently under evaluation. Changes to trabecular bone,  whole bone 
structure and hip strength estimations are limited to two research studies with and without pharmaceuticals.
Risk Disposition Rationale: Accepted for LEO/ISS missions, within 
standard limits.  Additional data are highly desired to refine standard.  Deep Space 
Sortie Accepted due to low probability of consequence.  Lunar and Deep Space 
Habitation requires optimization of exercise equipment/protocol and/or use of 
pharmaceuticals.  Planetary requires mitigation for potential operational impacts 
due to fracture from surface EVA and optimization for long term health due to long 
duration mission induced bone changes.
DRM 
Categories
Mission 
Duration
LxC Risk 
OPS
Disposition
LxC Risk 
LTH         
Disposition
Low Earth 
Orbit
6 
Months
1 x 4 Accepted 
Standard 
Refinement
2 x 3 Accepted 
Standard 
Refinement
1 
Year
1 x 4 Accepted
Standard 
Refinement
2 x 3 Accepted
Standard 
Refinement
Deep Space 
Sortie
1 
Month
1 x 4 Accepted
Low
Probability
1 x 3 Accepted
Low
Probability
Lunar Visit/
Habitation
1
Year
1 x 4 Accepted/
Optimize
2 x 3 Accepted/
Optimize
Deep Space 
Journey/Ha
b
1 
Year
1 x 4 Accepted/
Optimize
2 x 3 Accepted/
Optimize
Planetary 3 
Years
2 x 4 Requires
Mitigation
3 x 3 Accepted/
Optimize
Information
(*) Risk Custodian: J. Sibonga
